Active Not RecruitingNCT05769153
Study of AR-14034 in Participants With Neovascular Age-Related Macular Degeneration (nAMD)
PHASE1 · PHASE2 · 139 planned enrolment
- Countries listed
- 1
- Registry update
- August 27, 2026
Registry Intervention View
Aflibercept Injection
Trial registrations containing the exact intervention label Aflibercept Injection.
Exact registry label · Not reported
5 linked registrations
No aliases or equivalent products have been inferred.
Topics connected by trial metadata
0 linked registrations report posted results
This is a registry availability fact, not a safety result, comparison, or conclusion.
Understand the safety boundary →Registered trials
Active Not RecruitingNCT04101877
The Sahlgrenska Anti-VEGF Study
PHASE2 · 402 planned enrolment
- Countries listed
- 1
- Registry update
- November 21, 2025
Active Not RecruitingNCT06116890
Study to Assess the Efficacy & Safety of KHK4951 in Patients With Neovascular Age-Related Macular Degeneration
PHASE2 · 180 planned enrolment
- Countries listed
- 4
- Registry update
- October 30, 2025
Not Yet RecruitingNCT05251636
Adjunct Episcleral Brachytherapy for PCV
PHASE3 · 159 planned enrolment
- Countries listed
- 0
- Registry update
- August 30, 2023
UnknownNCT03594461
Intense Treatment Regimen With Intravitreal Aflibercept Injection
PHASE1 · PHASE2 · 30 planned enrolment
- Countries listed
- 1
- Registry update
- January 10, 2019